Please try another search
By Dhirendra Tripathi
Investing.com – Rite Aid (NYSE:RAD) slumped 14% Thursday as 2.2% growth in quarterly revenue fell short of expectations even as losses at the pharmacy chain narrowed sharply.
Revenue for the first quarter ended May 29 was $6.16 billion. The net loss was $13.1 million compared to $72.7 million in the same quarter a year ago.
In the first quarter, the pharmacy chain administered around 4.7 million Covid-19 vaccines compared to more than 2 million in March and mid-April.
The company has guided for an optimistic fiscal 2022.
Total revenue is seen between $25.1 billion and $25.5 billion. The net loss is seen coming between $138M million and $175 million.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.